Condition: Surgery · Obesity · NASH - Nonalcoholic Steatohepatitis · Sponsor: University Hospital, Lille
The aim of the study is to demonstrate the superiority of bariatric surgery on the disappearance of NASH without worsening of fibrosis in comparison to medical standard treatment in obese patients (35 kg/m² \> BMI ≥ 30 kg/m²) with NASH complicated of advanced fibrosis (F3 and F4 fibrosis grade according to Brunt score).
This description comes directly from the study's public registry record.
Philippe Mathurin, MD,PhD · 3 20 44 53 21 · philippe.mathurin@chru-lille.fr
Guillaume Lassailly, MD · 3 20 44 53 21 · guillaume.lassailly@chru-lille.fr
Always discuss trial participation with your own doctor first.
| Hôpital Claude Huriez, CHRU | Lille, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03472157